|
Investment Highlights Potential $485 million to $600 million market opportunity for the Company's pTeroPure product Client base includes the FDA, Cargill, Nestle, Kraft, Pfizer, and the USDA Nationwide launch of Company?s first retail product line, BluScience, in GNC stores in 3Q11 Global Industry Analysts, a market research firm, forecasts that the global nutraceutical market will reach $243 billion by 2015 Phillip Frost, a Forbes 400 billionaire and Vice Chairman of Teva Pharmaceuticals, is a key investor in the Company Partnered with global leaders Alcone and Chandler Chicco to advance proprietary products and branded retail lines http://www.redchip.com/visibility/investor.asp?symbol=CDXC |
|
| aus der Diskussion: | ChromaDex (smallcap) - A Philipp Frost (Billionair) Investment |
| Autor (Datum des Eintrages): | montamero (26.04.12 14:18:31) |
| Beitrag: | 17 von 129 (ID:43091535) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |